
Researchers at MIT have developed a machine learning algorithm that optimizes lipid nanoparticle (LNP) formulations for mRNA vaccines, enabling stability at room temperature. By analyzing nearly 50 FDA-approved excipients, the AI predicted combinations that protected RNA from degradation, allowing Moderna-style vaccines to remain effective after one year at room temperature or two months at 98°F. In mouse trials, these heat-stable vaccines elicited immune responses comparable to standard refrigerated doses and were successfully integrated into microneedle patches. The study, published in Nature Biotechnology, demonstrates that AI can accelerate the development of thermostable drug delivery systems for broader global access.
Read original
© WIRED AIAnthropic’s Claude identified a novel reverse transcriptase system in jumbo phages that resembles CRISPR, but the scientific community remains skeptical. While the speed of discovery is impressive, experts note the finding lacks wet-lab validation and may simply be pattern recognition on known data. The real story isn't a new gene-editing tool, but the opaque nature of how an AI model sifts through genomic databases to propose hypotheses that humans must still verify.
© Hugging Face BlogMost fact-checkers for AI agents only check if a claim is true in the evidence pool, ignoring where it came from. ProvenanceGuard fixes this by tracking source identity through every step of verification, catching cases where a true fact is wrongly attributed to the wrong tool or document. In medical agent tests, it caught 138 out of 139 incorrect attributions that standard verifiers missed, proving that provenance matters as much as truth in multi-tool environments. This shifts the focus from simple RAG retrieval to rigorous source-aware auditing for high-stakes applications.